These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9399605)

  • 21. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    Morrow JP; Cannon CP; Reiffel JA
    Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Class I drugs on atrial fibrillation.
    Steinbeck G; Remp T; Hoffmann E
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S104-8. PubMed ID: 9727684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.
    Slavik RS; Tisdale JE; Borzak S
    Prog Cardiovasc Dis; 2001; 44(2):121-52. PubMed ID: 11568824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.
    Stiell IG; Roos JS; Kavanagh KM; Dickinson G
    Am Heart J; 2010 Jun; 159(6):1095-101. PubMed ID: 20569725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
    Wang J; Feng J; Nattel S
    Circulation; 1994 Oct; 90(4):2032-40. PubMed ID: 7923691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs.
    Allessie MA; Wijffels MC; Dorland R
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S69-77. PubMed ID: 9727679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
    J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for conversion of atrial fibrillation.
    Dell'Orfano JT; Luck JC; Wolbrette DL; Patel H; Naccarelli GV
    Am Fam Physician; 1998 Aug; 58(2):471-80. PubMed ID: 9713400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Milan DJ; Saul JP; Somberg JC; Molnar J
    Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.